| Metric | FY2025 | FY2024 |
|---|---|---|
| General, selling, and administrative | $26.8M+33.2% | $20.1M |
| Research and development | $21.3M+25.3% | $17.0M |
| Total operating expenses | $48.1M+29.6% | $37.1M |
| Operating loss | -$48.1M-29.6% | -$37.1M |
| Other income | $4.2M+89.8% | $2.2M |
| Net Loss | -$43.9M-25.8% | -$34.9M |
| Weighted average loss per share of Class A and Class B common stock - basic | -$1790.00-17.8% | -$1520.00 |
| Weighted average loss per share of Class A and Class B common stock - diluted | -$1790.00-17.8% | -$1520.00 |
| Weighted average shares outstanding of Class A and B common stock - basic | 24.49B+6.3% | 23.04B |
| Weighted average shares outstanding of Class A and B common stock - diluted | 24.49B+6.3% | 23.04B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.